Back to top

Cullinan Therapeutics Inc Reports Q2 2025 EPS of -0. ...

Cullinan Therapeutics Inc Reports Q2 2025 EPS of -0.84, Aligns with Estimates; Net Loss Widens to $70.1 Million

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Cullinan Therapeutics, Inc. (CGEM)